Navigation Links
QRxPharma Announces Strategic Alliance with Liaoning Nuokang Medicines Co Ltd for the Development of Venomics Assets
Date:9/24/2009

and stopping blood flow (haemostasis) and has compared favourably to thrombin in pre-clinical testing. Both Haempatch(TM) and the native form of Textilinin were originally isolated from the venom of the Australian Common Brown snake (Pseudonaja textilis) by researchers at The University of Queensland (UQ). A collaborative R&D project has been ongoing since 2003 between QRxPharma and this UQ research team to further develop Textilinin and Haempatch(TM) and screen Australian snake venoms for therapeutic leads. A jointly owned pipeline of early stage candidates has been developed.

Forward Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties. The forward-looking statements contained herein represent the judgment of QRxPharma as of the date of this release. These forward-looking statements are not guarantees for future performance. Actual results could differ materially from those currently anticipated to due to a number of factors including risks relating to the stage of products under development; uncertainties relating to clinical trials; dependence on third parties; future capital needs; and risks relating to the commercialization of the Company's proposed products.

About QRxPharma

QRxPharma (ASX: QRX and Pink Sheets: QRXPY) is a clinical-stage specialty pharmaceutical company focused on the development and commercialisation of new treatments for pain management and central nervous system (CNS) disorders. Based on a development strategy which focuses on enhancing and expanding the clinical utility of currently marketed compounds, the Company's product portfolio includes both late and early stage clinical drug candidates with the potential for reduced risk, abbreviated development paths, and improved patient outcomes. The Company intends to directly commercialise its produ
'/>"/>

SOURCE QRxPharma Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. QRxPharma Expands Management Team with the Addition of Dr. Jesus Soriano as Executive Vice President
2. QRxPharma Begins Trading on the International OTCQX
3. QRxPharma Initiates Second Phase III Clinical Trial for its Dual Opioid Pain Therapy
4. I-Therapeutix, Inc. Announces Company Name Change
5. President Clinton Hosts Special Session on Northern Ireland; Announces New Commitments Focused on Harnessing Innovation for Development
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of Directors
7. US Farms, Inc. Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products
8. ReBuilder Medical Technologies, Inc. Announces Medicare Billing Ability for its ReBuilder Product
9. Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics (TCT) Meeting
10. Strategic Information Group Announces QAD Enterprise Validation Partnership
11. Natural Alternatives International, Inc. Announces Fiscal 2009 Q4 and Full Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... July 01, 2015 , ... During ... Posey (Manager, National Sales Training and Development) and Chuck Corso (Associate Sales Trainer) ... in Phoenix, AZ. LTEN brings together learning and development professionals from more than ...
(Date:7/1/2015)... ... July 01, 2015 , ... The 28th annual Charity Horse Show ... July 11, 2015, at 6 p.m. in Pugh Bourne Park, 343 Oakfield Road. The ... a petting zoo, an Elvis impersonator, a silent auction and concessions. , Horses and ...
(Date:7/1/2015)... , ... July 01, 2015 , ... As if mood ... found in a significant number of women: leg pain. Northeast Houston Vein Center is ... pain, a symptom of venous reflux disease, is underdiagnosed and often overlooked. Many women ...
(Date:7/1/2015)... ... July 01, 2015 , ... “Well-meaning social policy often has ... in FIU’s School of International and Public Affairs. , The researchers ... the National Survey on Drug Use and Health, which is a nationally representative ...
(Date:7/1/2015)... ... July 01, 2015 , ... RowdMap Inc. ... newly released white paper: “Pro-actively Identifying the High-Cost Patient Population: Insights from the ... is available at: http://www.hcttf.org/resouces-tools . , The Healthcare Transformation Task Force is ...
Breaking Medicine News(10 mins):Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3
... HLS ) today announced it will host an investor conference,call ... discuss its results for,the fourth quarter and year ended Dec. ... conference call may be accessed by dialing (866) 406-5369 and ... and,give the same pass code. Please call approximately 10 minutes ...
... Ohio, Dec. 17 EyeScience Labs announces the,availability of ... and dry eye syndrome at CVS Pharmacy stores ( ... (Photo: http://www.newscom.com/cgi-bin/prnh/20081217/CLW029-a ) , ... This marks the first time ...
... melanocortin-4 receptor controls blood pressure, study shows , , WEDNESDAY, ... obese individuals tend to have high blood pressure, but ... could explain that link. , In findings published in ... England Journal of Medicine , Sadaf Farooqi, of the ...
... procedure replaced 80% of severely disfigured woman,s face, physicians ... team of eight Cleveland Clinic surgeons has completed the ... of the woman,s face, including about 80 percent of ... of the sinuses, upper jaw -- essentially everything ...
... solution leading the pack for second straight year. , ... Suite (TM) with the trend-setting electronic bedboard (R) was ... providers who use automated patient flow solutions, according to healthcare market ... its large flat-panel display screen, the Bed ...
... At the request of the presidential transition team, ideas ... were provided today by the American College of Physicians ... and medical student members. It is the nation,s ... largest physician membership organization. , "ACP believes that it ...
Cached Medicine News:Health News:HealthSouth Announces Date of 2008 Fourth Quarter and Year-End Earnings Conference Call 2Health News:EyeScience's New Ocular Nutrition Supplements Available at CVS Stores 2Health News:Study Finds Molecular Link Between Obesity, Hypertension 2Health News:Study Finds Molecular Link Between Obesity, Hypertension 3Health News:Doctors Describe First U.S. Face Transplant 2Health News:Doctors Describe First U.S. Face Transplant 3Health News:Doctors Describe First U.S. Face Transplant 4Health News:TeleTracking Again Ranked KLAS 'Category Leader' 2Health News:Internists ask President-elect Obama to include aid for primary care in stimulus proposal 2Health News:Internists ask President-elect Obama to include aid for primary care in stimulus proposal 3
(Date:7/1/2015)... 2015 The Coalition of State Rheumatology ... regional professional rheumatology societies, today released the findings ... perceptions of biosimilars and the potential impact of ... Biosimilars are medicines that are highly similar, but ... different from generic medications in that it is ...
(Date:7/1/2015)... 2015 Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... presentation at the Cantor Fitzgerald Healthcare Conference in ... Russell Cox , executive vice president and chief operating ... business and financial update on Wednesday, July 8, 2015 at ... A live audio webcast of the presentation may be accessed ...
(Date:7/1/2015)... 2015 ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... commercialization of targeted antiviral therapies, announced today that it ... taking place in New York, NY ... Hotel. James Sapirstein , Chief ... business during his live presentation and will be available ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 2ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2
... HILLS, Calif., Sept. 15, 2011 HealthTech Capital, a ... emerging HealthTech market, announced today that it has closed ... from HealthTech Capital members in a Series B syndicated ... while Niveus Medical received $600,000 in a Series A ...
... Sept. 15, 2011 CarePoint Partners (CarePoint), a leading ... that it has acquired Mountain State Infusion Services (Mountain ... 14th acquisition in less than four years. CarePoint now ... and is one of the largest independent infusion therapy ...
Cached Medicine Technology:HealthTech Capital Announces Two New Investments in the Emerging HealthTech Market 2HealthTech Capital Announces Two New Investments in the Emerging HealthTech Market 3CarePoint Partners Expands Coverage in the Ohio Valley Region with Acquisition of Mountain State Infusion Services 2
Inquire...
Inquire...
... anti-reflux valve is enclosed in ... prevents the valve from being ... sitting or reclining positions. The ... interference free ensuring uninterrupted flow ...
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
Medicine Products: